Alternatives to BioNTech
BioNTech is a Biotechnology tool: global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases. Here are the 54 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to BioNTech
Moderna2.0 out of 5 (1)Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
ParcelBioNot ratedAdvancing next-generation mRNA medicines.
Mana.bioNot ratedAI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Anima BiotechNot ratedTech.Bio company advancing mRNA discovery with AI and its mRNA Lightning platform.
AdcendoNot ratedDeveloping first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.
CellCentricNot ratedA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
EnteromeNot ratedClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
InfinimmuneNot ratedDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
KaliVir Immunotherapeutics, Inc.5.0 out of 5 (1)Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Janux TherapeuticsNot ratedA clinical-stage biopharmaceutical company developing novel immunotherapies.
Sinopia BiosciencesNot ratedBiotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
Waypoint BioNot ratedAI-native biotech company designing next-generation CAR T therapies for solid tumors.
Brenus PharmaNot ratedClinical-stage immunotherapy company developing novel treatments for cancer.
LTZ TherapeuticsNot ratedImmunotherapy company targeting oncology and autoimmune diseases.
- GEGenexineNot rated
South Korean biopharmaceutical company developing novel biologics for cancer and rare diseases.
AN2 TherapeuticsNot ratedClinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.
Signadori BioNot ratedDeveloping a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
ImmunityBioNot ratedA commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.
Adaptimmune TherapeuticsNot ratedBiopharmaceutical company developing T-cell therapies for solid tumor cancers.
Telum TherapeuticsNot ratedBiotechnology company developing novel protein-based antimicrobial therapeutics.
Showing the next 20 closest matches. See the rest on the BioNTech profile.
Sponsored rows are paid and labelled. Advertise on this page

